Bed Bath & Beyond (BBBY) $2B Buyback Already Baked In, Says Goldman Sachs
Get Alerts BBBY Hot Sheet
Rating Summary:
4 Buy, 17 Hold, 14 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Goldman Sachs maintained a Sell rating on Bed Bath & Beyond (NASDAQ: BBBY) with a price target of $61. Earlier Bed Bath & Beyond announced that its Board of Directors has authorized a new $2.0 billion share repurchase program. Analyst Matthew J. Fassler thinks this is already largely backed in.
"We have already modeled buybacks beyond the completion of the current authorization. BBBY has committed to $2.861 bn of buybacks by year-end 2016; we were previously at $2.550 bn. Lifting our total to $2.850 bn, with the increment coming in 2016, leads us to hike our 2016 estimate by $0.04 to $5.64, while maintaining 2014/2015 at $4.97/$5.25," said Fassler.
"Note that we continue to prefer some injection of dividends into capital allocation for mature companies with challenged earnings streams. BBBY would need to add leverage to launch a dividend or buy back more stock, a notion this 8-K suggests is feasible (i.e. “various financing alternatives.”) BBBY has never had debt, though it has the capacity to add some, with rent-adjusted-debt to EBITDAR of 1.9X, near the low end of our coverage," he added.
For an analyst ratings summary and ratings history on Bed Bath & Beyond click here. For more ratings news on Bed Bath & Beyond click here.
Shares of Bed Bath & Beyond closed at $59.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- 29Metals Ltd (29M:AU) PT Lowered to AUD0.50 at RBC Capital
- Hennes & Mauritz AB (HMB:SS) (HNNMY) PT Raised to SEK190 at RBC Capital, 'showing some promising signs '
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Stock BuybacksRelated Entities
Goldman Sachs, Dividend, Stock Buyback, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!